tirzepatide pipeline 30mg (10mg/mL + B6 10mg/mL) (3mL Vial) GLP-1 Pipeline Update: February 2026

Key Studies on Duration of Treatment Effectiveness Randomized clinical trials help us see how long tirzepatide is effective

While not part of the approved prescribing information, some healthcare providers use compounded formulations to create more gradual dose escalation curves for sensitive patients

It targets two incretin hormones simultaneously, which is what sets it apart from GLP-1 only medications like semaglutide

7 The trial was a randomized, double-blind, placebo-controlled study in which 2,539 patients with a body mass index (BMI) 30 kg/m 2 or 27 kg/m 2 with at least one comorbidity other than T2DM were assigned to receive subcutaneous tirzepatide at a dose of 5 mg, 10 mg, or 15 mg or placebo once a week for 72 weeks

Novo Nordisk Inc